Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity

Cytokine

Volumn 33, Issue 3, 2006, Pages 129-137

  Chacon M R ^a   Richart, C ^a   Gomez J M ^b   Megia A ^a   Vilarrasa, N ^b   Fernandez Real J M ^c   Garcia Espana A ^a   Miranda, M ^a   Masdevall, C ^b   Ricard, W ^c   Caubet, E ^d   Soler, J ^b   Vendrell, J ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d Surgery Service   (Spain)

Author keywords

Adipocyte; Gene expression; Real time PCR; Stromovascular fraction; TNF family genes

Indexed keywords

CHLORDANE; FIBROBLAST GROWTH FACTOR INDUCIBLE 14 RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN TWEAK; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADIPOSE TISSUE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 33644893625     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.12.005     Document Type: Article

References (27)

1. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 2001 E745 E751
2. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance J Clin Invest 95 1995 2409 2415
3. P.A. Kern, M. Saghizadeh, J.M. Ong, R.J. Bosch, R.B. Deem, and R.B. Simsolo The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase J Clin Invest 95 1995 2111 2119
4. F.H. Hube, and H. Hauner The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture Endocrinology 141 2000 2582 2588
5. H.A. Koistinen, J.P. Bastard, E. Dusserre, P. Ebeling, N. Zegari, and F. Andreelli Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects Eur J Clin Invest 30 2000 302 310
6. M. Bullo, P. Garcia-Lorda, and J. Peinado-Onsurbe TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis Int J Obes Relat Metab Disord 26 2002 652 658
7. G.S. Hotamisligil, P. Arner, L.R. Atkinson, and B.M. Spiegelman Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance Diabetes 46 1997 451 455
8. F. Hube, M. Birgel, Y.M. Lee, and H. Hauner Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus Eur J Clin Invest 29 1999 672 678
9. Y. Chicheportiche, P.R. Bourdon, and H. Xu TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem 272 1997 32401 32410
10. S.R. Wiley, and J.A. Winkles TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TWEAKR/Fn14 receptor Cytokine Growth Factor Rev 14 2003 241 249
11. Y. Chicheportiche, R. Chicheportiche, I. Sizing, J. Thompson, C.B. Benjamin, and C. Ambrose Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects on anti-TWEAK monoclonal antibodies Arthritis Res 4 2002 126 133
12. N. Harada, M. Nakayama, H. Nakano, Y. Fukuchi, H. Yagita, and K. Okumura Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells Biochem Biophys Res Commun 299 2002 488 493
13. S. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
14. J.N. Fain, A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282
15. Y. Chicheportiche, L. Fossati-Jimack, S. Moll, N. Ibnou-ZeKri, and S. Izui Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies Biochem Biophys Res Commun 279 2000 162 165
16. S.H. Kim, Y.J. Kang, W.J. Kim, D.K. Woo, Y. Lee, and D.I. Kim TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages Circ J 68 2004 396 399
17. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, and C.J. Chou Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
18. World Health Organization Obesity: preventing and managing the global epidemic Report on WHO consultation on obesity 1997 World Health Organization Geneva, Switzerland WHO/NUT/NCD/98.1
19. J. Buren, S. Lindmark, F. Renström, and J.W. Eriksson In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism 52 2003 239 245
20. V. Mohamed-Ali, S. Goodrick, K. Bulmer, J.M. Holly, J.S. Yudkin, and S.W. Coppack Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo Am J Physiol 277 1999 E971 E975
21. M. Laimer, C.F. Ebenbichler, S. Kaser, A. Sandhofer, H. Weiss, and H. Nehoda Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention Int J Obes Relat Metab Disord 26 2002 659 662
22. J.M. Bruun, C. Verdich, S. Toubro, A. Astrup, and B. Richelsen Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men Eur J Endocrinol 148 2003 535 542
23. P. Dandona, A. Aljada, and A. Bandyopdhahyay Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 2004 4 7
24. M. Straczkowski, I. Kowalska, S. Dzienis-Straczkowska, A. Stepien, E. Skibinska, and M. Szelachowska Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance Eur J Endocrinol 145 2001 273 280
25. F. Ofei, S. Hurel, J. Newkirk, M. Sopwith, and R. Taylor Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 1996 881 885
26. A.S. Lihn, B. Richelsen, S.B. Pedersen, S.B. Haugaard, G.S. Rathje, and S. Madsbad Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels Am J Physiol Endocrinol Metab 285 2003 E1072 E1080
27. J.J. Boyle, P.L. Weissberg, and M.R. Bennett Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms Arterioscler Thromb Vasc Biol 23 2003 1553 1558